Organon & Co. (OGN)
(Delayed Data from NYSE)
$9.75 USD
+0.05 (0.52%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $9.64 -0.11 (-1.13%) 7:58 PM ET
2-Buy of 5 2
A Value F Growth C Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Organon & Co. has a market cap of $2.52B, which represents its share price of $9.70 multiplied by its outstanding shares number of 259.96M. As a mid-cap company, OGN's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
OGN 9.75 +0.05(0.52%)
Will OGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OGN
Insights Into Organon (OGN) Q2: Wall Street Projections for Key Metrics
Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
OGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy?
Organon (OGN) Outperforms Broader Market: What You Need to Know
Other News for OGN
Organon & Co (OGN) to Announce Second Quarter 2025 Financial Results | OGN stock news
Organon To Report Second Quarter 2025 Results and Host Conference Call on August 5, 2025 | OGN ...
Organon & Co (OGN) Faces Securities Fraud Class Action Lawsuit | OGN stock news
OGN September 19th Options Begin Trading
XPH: Healthcare Dashboard For July